Infographic | December 13, 2024

Top 10 Tips For Diversity Plans

Source: Citeline
10 Ten Tips

In June 2024, the FDA issued updated guidance to enhance diversity in clinical trials, emphasizing the development of comprehensive Diversity Action Plans. These plans are designed to address various dimensions of diversity, extending beyond age, ethnicity, sex, and race. Sponsors are required to set clear goals for enrolling diverse populations, informed by the disease's epidemiology across different groups. Study designs and eligibility criteria must be inclusive, with strategic site selections in areas with high concentrations of underrepresented groups to facilitate participation. The guidance underscores the importance of utilizing diverse data sources, including real-world data, to justify enrollment targets and address gaps in epidemiological data. Additionally, forming strategic partnerships with experts in epidemiology and clinical trial diversity is recommended to bolster diversity action plans and achieve representative enrollment.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader